Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Miller

Showing results (421-430 of 768) with videos related to

Pageof 77
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Brain : a Journal of Neurology|October 26, 2000
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosisP D Molyneux, L Kappos, C Polman, et al.
Neurology|August 17, 1999
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study GroupN Tubridy, P O Behan, R Capildeo, et al.
Neurology|January 5, 2002
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MSP D Molyneux, G J Barker, F Barkhof, et al.
Brain : a Journal of Neurology|July 29, 2005
A longitudinal study of cognition in primary progressive multiple sclerosisS J Camp, V L Stevenson, A J Thompson, et al.
Neurology|March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MSM Inglese, J H T M van Waesberghe, M Rovaris, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Brain : a Journal of Neurology|July 2, 1999
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlatesS J Camp, V L Stevenson, A J Thompson, et al.
Neurology|August 1, 1997
Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trialsM Filippi, J H van Waesberghe, M A Horsfield, et al.
Annals of Neurology|April 18, 1998
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisM Filippi, M A Horsfield, H J Adèr, et al.
Pageof 77

Showing results (421-430 of 768) with videos related to

Sort By:
Pageof 77
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Brain : a Journal of Neurology|October 26, 2000
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosisP D Molyneux, L Kappos, C Polman, et al.
Neurology|August 17, 1999
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study GroupN Tubridy, P O Behan, R Capildeo, et al.
Neurology|January 5, 2002
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MSP D Molyneux, G J Barker, F Barkhof, et al.
Brain : a Journal of Neurology|July 29, 2005
A longitudinal study of cognition in primary progressive multiple sclerosisS J Camp, V L Stevenson, A J Thompson, et al.
Neurology|March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MSM Inglese, J H T M van Waesberghe, M Rovaris, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, W Roser, et al.
Brain : a Journal of Neurology|July 2, 1999
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlatesS J Camp, V L Stevenson, A J Thompson, et al.
Neurology|August 1, 1997
Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trialsM Filippi, J H van Waesberghe, M A Horsfield, et al.
Annals of Neurology|April 18, 1998
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisM Filippi, M A Horsfield, H J Adèr, et al.
Pageof 77